HR 3731 · 119th Congress · Health
Small Biotech Innovation Act
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.(2025-06-04)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 3731 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 3731 To amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES June 4, 2025 Mr. Pfluger (for himself and Mr. Kustoff) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTIO…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (3)
1 Democrat2 Republicans